565 The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming.
http://www.nature.com/ncomms/2015/150716/ncomms8530/full/ncomms8530.html
564 Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.
http://www.nature.com/nature/journal/v523/n7560/full/nature14406.html
563 Progesterone receptor modulates ERα action in breast cancer.
http://www.nature.com/nature/journal/v523/n7560/full/nature14583.html
562 Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract (Review).
http://stke.sciencemag.org/content/8/385/re8.abstract
561 Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity.
http://www.nature.com/nature/journal/v523/n7559/full/nature14404.html
560 Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
http://www.nature.com/nature/journal/v523/n7559/full/nature14581.html
559 MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis.
http://www.nature.com/nature/journal/v523/n7558/full/nature14351.html
558 Grb2 monomer–dimer equilibrium determines normal versus oncogenic function.
http://www.nature.com/ncomms/2015/150624/ncomms8354/full/ncomms8354.html
557 Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
http://www.nature.com/ncomms/2015/150624/ncomms8553/full/ncomms8553.html
556 Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia.
http://stm.sciencemag.org/content/7/293/293ra102
555 Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography.
http://stm.sciencemag.org/content/7/292/292ra100
554 Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.
http://stm.sciencemag.org/content/7/291/291ra94
553 Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer.
http://stke.sciencemag.org/content/8/379/ra53.abstract
552 α-Enolase–targeted lipid nanoparticles containing chemotherapeutic drugs are effective for the treatment of colorectal cancer.
http://stm.sciencemag.org/content/7/290/290ra91.abstract
551 An “organelle knockout” strategy reveals that cancer cells but not normal cells can divide in the absence of centrosomes.
http://www.sciencemag.org/content/348/6239/1155.abstract
550 The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.
http://www.nature.com/nature/journal/v522/n7554/full/nature14492.html
549 Probiotics programmed to generate specific metabolites traffic from the gut to tumors and enable cancer detection through the urine.
http://stm.sciencemag.org/content/7/289/289ra84.abstract
548 A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates.
http://stm.sciencemag.org/content/7/289/289ra82
547 Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
http://jco.ascopubs.org/content/early/2015/05/22/JCO.2014.58.3377.abstract?sid=25367564-a56b-46d4-b1d0-c0af42ba0d65
546 Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth.
http://www.nature.com/ncomms/2015/150526/ncomms8215/full/ncomms8215.html
|
